GDOC GOLDMAN SACHS FUTURE HEALTH CARE EQUITY ETF
- 33.250
- +0.178+0.54%
Research Alert: CFRA Keeps Buy Opinion On Shares Of Danaher Corporation
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Following better-than-anticipated Q1 res
What's in the Cards for Amgen (AMGN) This Earnings Season?
UPDATE 1-One Dose of Novo Nordisk's Wegovy Back in Supply, FDA Website Shows
DexCom, Insulet, Tandem Seen Benefitting the Most in Diabetes Survey - Wells Fargo
Insights Into Amgen (AMGN) Q1: Wall Street Projections for Key Metrics
Dow futures rose and financial results continued this week, FOMC results were announced, and US employment statistics = US stocks over the weekend
Both Dow futures, S&P 500, and NASDAQ 100 have risen in the US stock index futures market, and it seems that today will continue to grow and begin. Settlement of IT/high-tech stocks began last week, but there is generally a lot of good content, and a sense of security is spreading in the market.
How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q1 Earnings Report
Eli Lilly and Company (NYSE:LLY) is set to report first-quarter earnings on Tuesday, April 30.Analysts expect the Indianapolis, Indiana-based company's quarterly earnings to be $2.46 per share, up fro
Express News | Danaher Corp : Raymond James Raises Target Price to $285 From $270
Economic schedule for 30th (Tue) ★ Amazon, AMD financial results, etc.
4/30 (Tue) Akaguchi, Moon Age 21.4 “4 wins and 6 losses” (taking the Nikkei average for the past 10 years) [Domestic] ★ March Complete Unemployment Rate (8:30) ★ March Effective Job Offer Ratio (8:30) ★ March Industrial Production (8:50) □ March Commercial Dynamics Statistics (8:50) □ FY23 and March Construction Equipment Shipments (13:00) □ March Automobile Export Results (13:00) □ March Automobile Export Results (13:00) □ March New Housing Construction Starts (14:00) □ Implementation Status of Foreign Exchange Balance Operations (19:00) [Overseas] new Manufacturing PMI (10:45)
Should Weakness in Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
It is hard to get excited after looking at Zimmer Biomet Holdings' (NYSE:ZBH) recent performance, when its stock has declined 9.6% over the past month. But if you pay close attention, you might find
Raymond James Adjusts Price Target on Danaher to $285 From $270, Keeps Outperform Rating
Danaher (DHR) has an average outperform rating and a price target range of $208 to $300, according to analysts polled by Capital IQ. Price: 246.23, Change: -0.35, Percent Change: -0.14
J&J, Roche, AstraZeneca Poised to Have Highest Orphan Drug Sales by End of Decade
What Do Weight-loss Drugs Mean for the Diet Industry?
Amgen's Blincyto Data Send Cullinan Higher
Cullinan Therapeutics (NASDAQ:CGEM) drew Wall Street's attention last week as William Blair touted the stock after peer-reviewed data for Amgen's (NASDAQ:AMGN) leukemia therapy, Blincyto, which targets CD19 surface antigens on B cells similar to CGEM's lymphoma candidate CLN-978.
Is Cooper Companies (NASDAQ:COO) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only n
Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: 'We Have To Run Such A Ridiculous Gauntlet Next Week'
Jim Cramer, the host of CNBC's "Mad Money," has outlined the key events that investors should keep an eye on in the upcoming week.What Happened: Cramer highlighted the significant events scheduled for
Form 144 | Boston Scientific(BSX.US) Director Proposes to Sell 719.56K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 26, $Boston Scientific(BSX.US)$ Director LUDWIG EDWARD J intends to sell 9,818 shares of its common stock on Apr 26, with a total market value of approximately $719.56K.
Insulet (PODD) Outperforms Broader Market: What You Need to Know
Danaher(DHR.US) Officer Sells US$5.62 Million in Common Stock
$Danaher(DHR.US)$ Officer Weidemanis Joakim sold 22,433 shares of common stock on Apr 25, 2024 at an average price of $250.46 for a total value of $5.62 million.Source: Announcement What is statement
Danaher Insider Sold Shares Worth $5,618,569, According to a Recent SEC Filing
Joakim Weidemanis, Executive Vice President, on April 25, 2024, sold 22,433 shares in Danaher (DHR) for $5,618,569. Following the Form 4 filing with the SEC, Weidemanis has control over a total of 90,